Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

2.10
-0.0400-1.87%
Pre-market: 2.110.0100+0.48%06:00 EDT
Volume:102.84K
Turnover:218.07K
Market Cap:171.49M
PE:-18.86
High:2.19
Open:2.14
Low:2.09
Close:2.14
Loading ...

I-Mab to Present at the BTIG Virtual Biotechnology Conference

GlobeNewswire
·
14 Jul

I-MAB Amends Prospectus for $21 Million ADS Offering

TIPRANKS
·
12 Jul

I-Mab May Offer and Sell Ads Having Aggregate Offering Price of up to $50 Mln- SEC Filing

THOMSON REUTERS
·
12 Jul

I-Mab Price Target Maintained With a $5.00/Share by Needham

Dow Jones
·
09 Jul

I-MAB’s Givastomig Shows Promising Efficacy and Safety in Gastric Cancer, Earning Buy Rating

TIPRANKS
·
09 Jul

I-Mab Unveils Corporate Presentation Highlighting Innovative Drug Development and Promising Cancer Therapies

Reuters
·
03 Jul

I-Mab presents Gibastomig Phase 1b dose escalation data

TIPRANKS
·
02 Jul

I-Mab to Present Positive Phase 1b Givastomig Data at ESMO GI 2025

Reuters
·
02 Jul

I-Mab publishes givastomig monotherapy data in Clinical Cancer Research

TIPRANKS
·
01 Jul

I-Mab Is Maintained at Buy by Needham

Dow Jones
·
27 Jun

Promising Clinical Data and Rapid Enrollment Propel I-MAB’s Givastomig to a Buy Rating

TIPRANKS
·
27 Jun

Promising Developments in Gastric Cancer Treatment: I-MAB’s Givastomig Earns Buy Rating

TIPRANKS
·
26 Jun

I-Mab Announces Promising Phase 1b Trial Results for Givastomig in Combination with Immunochemotherapy for Gastric Cancer at ESMO GI 2025

Reuters
·
26 Jun

I-Mab Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
12 Jun

Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
09 Jun

I-Mab Unveils Corporate Presentation Highlighting Advancements in Givastomig for Gastric Cancer and Strategic Growth Initiatives

Reuters
·
02 Jun

I-MAB Strengthens Board with New Appointment of Dr. Sean Cao

TIPRANKS
·
30 May

I-Mab initiated with a Buy at Lucid Capital

TIPRANKS
·
28 May

I-Mab to Present at Jefferies Global Healthcare Conference

GlobeNewswire
·
20 May

Analysts Offer Insights on Healthcare Companies: I-MAB (IMAB) and Durect (DRRX)

TIPRANKS
·
18 May